Partners
The consortium, led by University of Iceland, consists of 16 partners from 10 countries:
Iceland, Sweden, Spain, Finland, France, Netherlands, Belgium, Ukraine, Czechia and Germany.
The partners, most of them experienced in EU projects, will boost the management of the project, which aims to optimize Therapeutic Epigenetic Enhancement of the Innate Immunity to Effectively Combat Antimicrobial Resistance (AMR).
This project has received funding from the European Union´s Horizon Europe research
and innovation programme under grant agreement No 101080889.
Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.”
This project has received funding from the European Union´s Horizon Europe research and innovation programme under grant agreement No 101080889.
Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.”
